Evidence map›Paper›PMID 37434654›Full record

ArticleTherapeutic advances in infectious disease

The global prevalence of human fascioliasis: a systematic review and meta-analysis.

Luis Raúl Rosas-Hostos Infantes, Guillermo Andres Paredes Yataco, Yeimer Ortiz-Martínez, Treana Mayer, Angelica Terashima, Carlos Franco-Paredes, Esteban Gonzalez-Diaz, Alfonso J Rodriguez-Morales, D Katterine Bonilla-Aldana, Lilian Vargas Barahona and 5 more

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. AdultASM case reports · 2026
    Article
  3. Case report: Schistosoma mansoni and Fasciola spp. co-infection.Tropical diseases, travel medicine and vaccines · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Design of a Multi-Epitope Vaccine Based onInternational journal of molecular sciences · 2025
    Article
  12. Review
  13. Infection rates ofFood and waterborne parasitology · 2025
    Article
  14. In Vitro Effects of Vanadate Erbium/Silver Oxide (ErVOVeterinary medicine and science · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 7 countries.

Luis Raúl Rosas-Hostos InfantesFacultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Perú.
Guillermo Andres Paredes YatacoFacultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Perú.
Yeimer Ortiz-MartínezDepartment of Internal Medicine, Universidad Industrial de Santander and Hospital Universitario de Santander, Bucaramanga, Colombia.
Treana MayerDepartment of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, CO, USA.
Angelica TerashimaLaboratorio de Parasitología, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Carlos Franco-ParedesHospital Infantil de México Federico Gómez, México City, México.
Esteban Gonzalez-DiazEpidemiological Surveillance and Preventive Medicine Unit, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.
Alfonso J Rodriguez-MoralesGrupo de Investigación Biomedicina, Faculty of Medicine, Fundacion Universitaria Autónoma de las Américas-Institucion Universitaria Vision de las Americas, Pereira, Risaralda, Colombia.ORCID https://orcid.org/0000-0001-9773-2192
D Katterine Bonilla-AldanaResearch Unit, Universidad Continental, Huancayo, Peru.
Lilian Vargas BarahonaDivision of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID https://orcid.org/0000-0003-3330-808X
Alyssa A GrimshawYale University, New Haven, CT, USA.
Daniel B ChastainDepartment of Clinical & Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA, USA.ORCID https://orcid.org/0000-0002-4018-0195
Stefan SillauDepartment of Neurology and Biostatistics, University of Colorado School of Medicine, Aurora, CO, USA.
Luis A MarcosDivision of Infectious Diseases, Departments of Medicine, Microbiology and Immunology, Stony Brook University, Stony Brook, NY, USA.
Andrés F Henao-MartínezUniversity of Colorado Anschutz Medical Campus, 12700 E. 19th Avenue, Mail Stop B168, Aurora, CO 80045, USA. Universidad Cientifica del Sur, Lima, Peru andres.ORCID https://orcid.org/0000-0001-7363-8652
Universidad Peruana Cayetano Heredia · PEUniversidad Científica del Sur · PEColorado State University · USGeorgia College & State University · USHospital Civil de Guadalajara · MXIndustrial University of Santander · COInstituto Conmemorativo Gorgas de Estudios de la Salud · PAStony Brook University · USUniversidad Continental · PEUniversity of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Fascioliasis is a parasitic zoonosis that can infect humans and be a source of significant morbidity. The World Health Organization lists human fascioliasis as a neglected tropical disease, but the worldwide prevalence of fascioliasis data is unknown. Objective: We aimed to estimate the global prevalence of human fascioliasis. Data sources and methods: We performed a systematic review and prevalence meta-analysis. We used the following inclusion criteria: articles published in the English, Portuguese, or Spanish languages from December 1985 to October 2022 and studies assessing the prevalence of Results: In all, 5617 studies were screened for eligibility. Fifty-five studies from 15 countries were selected, including 154,697 patients and 3987 cases. The meta-analysis revealed a pooled prevalence of 4.5% [95% confidence interval (CI): 3.1-6.1; Conclusion: The estimated prevalence and projected disease burden of human fascioliasis are high. Study findings support that fascioliasis continues to be a globally neglected tropical disease. Strengthening epidemiological surveillance and implementing measures to control and treat fascioliasis is imperative in the most affected areas.

Indexed as

epidemiologyF. giganticaF. hepaticahuman fascioliasismeta-analysisneglected tropical diseaseprevalencesystematic review

Identifiers

PMID37434654
PMCPMC10331341
OpenAlexW4383647246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.